Correlation of molecular subtypes with survival in AVAglio (bevacizumab [Bv] and radiotherapy [RT] and temozolomide [T] for newly diagnosed glioblastoma [GB]).
Heidi Phillips
Employment or Leadership Position - Merck (I)
Consultant or Advisory Role - Genentech
Stock Ownership - Merck (B)
Thomas Sandmann
Employment or Leadership Position - Genentech
Congfen Li
Employment or Leadership Position - Genentech
Timothy Francis Cloughesy
Consultant or Advisory Role - Apogenix; Celgene; Genentech; Merck; Merck Serono; NewGen Therapeutics; Roche; Tocagen
Olivier L. Chinot
Consultant or Advisory Role - Roche
Honoraria - AstraZeneca; MSD; Roche
Research Funding - Roche; Schering-Plough
Wolfgang Wick
Consultant or Advisory Role - Lilly (U); MSD; Roche
Research Funding - Apogenix; Boehringer Ingelheim; Lilly; MSD; Roche
Ryo Nishikawa
Consultant or Advisory Role - Roche
Warren P. Mason
Consultant or Advisory Role - Roche
Roger Henriksson
Consultant or Advisory Role - Roche
Frank Saran
Consultant or Advisory Role - Roche
Albert Lai
Consultant or Advisory Role - Roche/Genentech
Nicola Moore
Employment or Leadership Position - Roche
Stock Ownership - Roche
Priti S. Hegde
Employment or Leadership Position - Genentech
Lauren E. Abrey
Employment or Leadership Position - Roche
Stock Ownership - Roche
Richard Bourgon
Employment or Leadership Position - Genentech
Josep Garcia
Employment or Leadership Position - Roche
Carlos Bais
Employment or Leadership Position - Roche/Genentech
Stock Ownership - Roche
Research Funding - Roche/Genentech